Healthcare
Global

Healthcare Experts

Somu Subramaniam

Co Founder
Healthcare
Resolve
United States of America

Biography

 Somu Subramaniam is the co-founder and Managing Partner of New Science Ventures. Somu serves on the Board of Directors of Achronix Semiconductor Corporation, Alexar Therapeutics, Ario Pharmaceuticals, Cambridge Epigenetix, Dali Wireless, Oxyrane UK, Resolve Therapeutics, Svelte Medical Systems, Vascular Therapies, Vaultive, and iCAD. Somu has also served on the Boards of Dezima Pharma (acquired by Amgen), Ception Therapeutics (acquired by Cephalon), BioVex (acquired by Amgen), Lightwire (acquired by Cisco) and K2M (acquired by Welsh Carson). Prior to founding NSV, Somu was a director at McKinsey & Company where he advised leading multinational companies in the pharmaceuticals, medical devices, biotechnology, photonics, software and semiconductor industries. At McKinsey, Somu was leader of the Strategy Practice, the Technology Practice, the Biotechnology Group, and the Healthcare Practice. He also served on the firm’s Investment Committee and led its Equity Portfolio Committee. Somu holds a B.Tech. degree from the Indian Institute of Technology and an M.B.A. from Harvard Business School.

Research Interest

 Somu Subramaniam is the co-founder and Managing Partner of New Science Ventures. Somu serves on the Board of Directors of Achronix Semiconductor Corporation, Alexar Therapeutics, Ario Pharmaceuticals, Cambridge Epigenetix, Dali Wireless, Oxyrane UK, Resolve Therapeutics, Svelte Medical Systems, Vascular Therapies, Vaultive, and iCAD. Somu has also served on the Boards of Dezima Pharma (acquired by Amgen), Ception Therapeutics (acquired by Cephalon), BioVex (acquired by Amgen), Lightwire (acquired by Cisco) and K2M (acquired by Welsh Carson). Prior to founding NSV, Somu was a director at McKinsey & Company where he advised leading multinational companies in the pharmaceuticals, medical devices, biotechnology, photonics, software and semiconductor industries. At McKinsey, Somu was leader of the Strategy Practice, the Technology Practice, the Biotechnology Group, and the Healthcare Practice. He also served on the firm’s Investment Committee and led its Equity Portfolio Committee. Somu holds a B.Tech. degree from the Indian Institute of Technology and an M.B.A. from Harvard Business School.

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recommended Conferences
  • 2nd Global Public Health Congress

    March 25-26, 2019 Rotterdam, Netherlands

  • 6th European Epidemiology and Public Health Congress

    April 29-30, 2019 Helsinki, Finland

  • 7th World Congress on Public Health, Nutrition & Epidemiology

    May 15-16, 2019 Singapore City, Singapore

  • 4th World Congress on Patient Safety & Quality Healthcare

    June 27-28, 2019 Vienna, Austria

  • 8th International Conference on Public Health and Nursing

    August 14-15, 2019 Tokyo, Japan

  • 11th International Conference on Epidemiology & Public Health

    September 26-27, 2019 Copenhagen, Denmark

  • 5th World Congress on Health Economics, Health Policy and Healthcare Management

    October 14-15, 2019 Warsaw, Poland Warsaw, Poland

  • 8th International Conference on Epidemiology & Public Health

    October 23-24, 2019 Tokyo, Japan

View more